Table 1.
Baseline characteristics of included studies
| Study | No of patients, n | Mean age in years (SD) | Male % | Follow-up (yr) | Aspect score at admission, median (IQR) | Occlusion location | Diabetes % | Hypertension % | Atrial fibrillation % | NIHSS at admission | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Internal carotid artery (%) | Middle cerebral artery M1 (%) | Middle cerebral artery M2 (%) | Basilar artery (%) | Intervention | Control | ||||||||
| MR CLEAN-LATE 2024 | 502 | 72.86 (12.20) | 48 | 2 | 9 (7–10) | 8 (7–9) | 2.3 | 52 | 31 | N/R | 14.8 | 52.1 | 20.8 | 10[6–15] | 10[6–16] |
| TENSION 2024 | 253 | 72.8 (11.9) | 51 | 1 | N/R | N/R | 30.8 | 67.5 | 0.39 | N/R | 23.3 | 80.7 | 33.6 | 19 (4.5001) | 18.3515 (5.2486) |
| SELECT-2 2024 | 352 | 66.4 (12.6) | 58.8 | 1 | 4 (3–5) | 4 (4–5) | 41.4 | 54.2 | 4.26 | N/R | 30.6 | 73.8 | 24.14 | 19 (5.9792) | 18.6489 (5.2328) |
| LASTE 2024 | 324 | 72.8 (10.5) | 52.4 | 0.5 | 2 (1–3) | 2 (1–3) | 44.1 | 55.2 | NR | N/R | NR | NR | NR | 21 (4.4888) | 21 (4.4873) |
| ATTENTION 2024 | 330 | 66.1 (15.07) | 68.8 | 1 | 9 (8–10) | 10 (8–10) | N/R | N/R | N/R | 100 | N/R | N/R | N/R | 23 (13−35) | 25 (13−35) |
| MR CLEAN 2017 | 391 | 66.45(10.44) | 58.5 | 2 | 9 (8–10) | 9 (8–10) | 0.5 | 64.9 | 7.41 | N/R | 13.8 | NR | 24.8 | 17.351 (5.2283) | 18 (5.9745) |
| REVASCAT 2017 | 206 | NR | 52.9 | 1 | 7 (6–9) | 8 (6–9) | 0.4 | 63.5 | 8.73 | N/R | 19.9 | 65 | 34.9 | 17 (4.5113) | 15.9443 (5.2632) |